Johnson & Johnson rides strong prescription sales in 1Q

Johnson & Johnson on Tuesday posted a 0.6 percent decline in first-quarter profit, but still beat Wall Street's expectations as strong sales of prescription drugs nearly offset a big hit from the strong dollar.